|
Volumn 29, Issue 11, 2010, Pages 1318-
|
H1N1 influenza vaccination and infection in pediatric heart transplants
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
INFLUENZA VACCINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OSELTAMIVIR;
TACROLIMUS;
ABSENCE OF SIDE EFFECTS;
ADOLESCENT;
ASSISTED VENTILATION;
BLOOD CULTURE;
BRONCHIOLITIS;
CARDIAC GRAFT REJECTION;
CHILD;
CLINICAL FEATURE;
CONFIDENCE INTERVAL;
COUGHING;
FEVER;
HEART GRAFT;
HEART TRANSPLANTATION;
HOME CARE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION PREVENTION;
INFLUENZA A (H1N1);
LETTER;
OUTPATIENT DEPARTMENT;
OXYGEN THERAPY;
PRIORITY JOURNAL;
RESPIRATORY TRACT DISEASE;
RESPIRATORY TRACT INFECTION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RISK FACTOR;
SERRATIA MARCESCENS;
TRACHEOSTOMY;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSION;
INCIDENCE;
INFANT;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
MALE;
RETROSPECTIVE STUDIES;
RISK FACTORS;
SPAIN;
TREATMENT OUTCOME;
VIRAL VACCINES;
|
EID: 78049285256
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/j.healun.2010.07.011 Document Type: Letter |
Times cited : (6)
|
References (6)
|